ERBB3 blockade sensitizes hepatocellular carcinoma to regorafenib after first-line tyrosine kinase inhibitor resistance by inhibiting HIF1A-ABCB1 signaling
Baorui Tao(Huashan Hospital)
Cited by 1
Related Papers
No related papers found
Powered by citation graph analysis